164 related articles for article (PubMed ID: 8384036)
1. Herpesviruses: expression of genes in postmitotic brain cells.
Geller AI
Curr Opin Genet Dev; 1993 Feb; 3(1):81-5. PubMed ID: 8384036
[TBL] [Abstract][Full Text] [Related]
2. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
[TBL] [Abstract][Full Text] [Related]
3. Plasmid insertion vectors that facilitate construction of herpes simplex virus gene delivery vectors.
Weir JP; Dacquel EJ
Gene; 1995 Feb; 154(1):123-8. PubMed ID: 7867939
[TBL] [Abstract][Full Text] [Related]
4. Amplicon-based herpes simplex virus vectors.
Ho DY
Methods Cell Biol; 1994; 43 Pt A():191-210. PubMed ID: 7823862
[No Abstract] [Full Text] [Related]
5. Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac.
Geller AI
J Virol Methods; 1991; 31(2-3):229-38. PubMed ID: 1650784
[TBL] [Abstract][Full Text] [Related]
6. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.
Geller AI; Breakefield XO
Science; 1988 Sep; 241(4873):1667-9. PubMed ID: 2843986
[TBL] [Abstract][Full Text] [Related]
7. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.
Geller AI
J Neurosci Methods; 1991 Jan; 36(1):91-103. PubMed ID: 1648153
[TBL] [Abstract][Full Text] [Related]
8. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
Frenkel N; Singer O; Kwong AD
Gene Ther; 1994; 1 Suppl 1():S40-6. PubMed ID: 8542394
[TBL] [Abstract][Full Text] [Related]
9. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
Geller AI; Keyomarsi K; Bryan J; Pardee AB
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
[TBL] [Abstract][Full Text] [Related]
10. Gene delivery to neurons: is herpes simplex virus the right tool for the job?
Leib DA; Olivo PD
Bioessays; 1993 Aug; 15(8):547-54. PubMed ID: 8135768
[TBL] [Abstract][Full Text] [Related]
11. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication.
Weindler FW; Heilbronn R
J Virol; 1991 May; 65(5):2476-83. PubMed ID: 1850024
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus vectors for gene therapy.
Latchman DS
Mol Biotechnol; 1994 Oct; 2(2):179-95. PubMed ID: 7866875
[TBL] [Abstract][Full Text] [Related]
15. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
Ikeda K; Wakimoto H; Ichikawa T; Jhung S; Hochberg FH; Louis DN; Chiocca EA
J Virol; 2000 May; 74(10):4765-75. PubMed ID: 10775615
[TBL] [Abstract][Full Text] [Related]
16. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
[No Abstract] [Full Text] [Related]
17. Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system.
Gao Q; Sun M; Wang X; Zhang GR; Geller AI
Brain Res; 2006 Apr; 1083(1):1-13. PubMed ID: 16545782
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase.
Boviatsis EJ; Scharf JM; Chase M; Harrington K; Kowall NW; Breakefield XO; Chiocca EA
Gene Ther; 1994 Sep; 1(5):323-31. PubMed ID: 7584098
[TBL] [Abstract][Full Text] [Related]
19. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
Fraser NW; Valyi-Nagy T
Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
[No Abstract] [Full Text] [Related]
20. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
